People living with HIV in poor socio-economic circumstances are selling their HIV meds to negative people to use as PrEP (pre-exposure prophylaxis). The most common antiretroviral sold is Truvada with sellers earning up to $100 for a month’s supply.
According to a US study, the main reasons for selling antiretrovirals were because the person needed money for alcohol or drugs (74 percent), or for living expenses (23 percent). Health professionals warn against informal use of PrEP, however. Risks include sporadic supply, lack of regular HIV testing, lack of STI screening, lack of side-effects monitoring, and counterfeit pills.